Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3256 |
MMAF
一甲基澳瑞他汀 F,MonoMethyl auristatin F |
Others; Microtubule Associated | Cytoskeletal Signaling; Others |
MMAF (MonoMethyl auristatin F) 是一种抗有丝分裂剂,通过阻断微管蛋白的聚合来抑制细胞分裂,用作抗肿瘤药物和抗体偶联药物的细胞毒性成分。 | |||
T12081 |
MMAF-OMe
Monomethyl auristatin F methyl ester |
||
MMAF-OMe (Monomethyl auristatin F methyl ester) 是一种抗微管蛋白剂,能够抑制 MDAMB435/5T4,MDAMB361DYT2,MDAMB468 和 Raji (5T4-) 这四种肿瘤细胞,IC50值分别为 0.056 nM,0.166 nM,0.183 nM 和 0.449 nM。它也是ADC 细胞毒素。 | |||
T39897 |
DBCO-PEG4-MMAF
DBCO-PEG4-MMAF |
||
DBCO-PEG4-MMAF is an antibody-drug conjugate (ADC) component that exhibits potent antitumor activity. It combines the tubulin polymerization inhibitor MMAF with a cleavable linker, DBCO-PEG4, to target cancer cells effectively. | |||
T38830 |
Modified MMAF-C5-COOH
Modified MMAF-C5-COOH |
||
Modified MMAF-C5-COOH is a drug-linker conjugate for ADC. | |||
T39748 |
DBCO-PEG4-Val-Cit-PAB-MMAF
DBCO-PEG4-Val-Cit-PAB-MMAF |
||
DBCO-PEG4-Val-Cit-PAB-MMAF is a chemical compound that comprises a cleavable 4 unit polyethylene glycol antibody-drug conjugate (ADC) linker known as DBCO-PEG4-Val-Cit-PAB, and a highly effective inhibitor of tubulin polymerization called MMAF. This compound serves as a valuable component in the synthesis of ADCs. | |||
T39238 |
DBM-MMAF
|
||
DBM-MMAF is a drug-linker conjugate composed of a potent antitubulin agent MMAF and a linker DBM to make antibody drug conjugate (ADC). | |||
T10949 |
D8-MMAF
Monomethylauristatin F D8 |
Others | Others |
D8-MMAF is a microtubule destroyer, deuterated form of MMAF. | |||
T16121 |
MMAF Hydrochloride
Monomethylauristatin F Hydrochloride |
Others | Others |
MMAF Hydrochloride is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A. MMAF Hydrochloride is an effective tubulin polymerization inhibitor and is used as an antitumor compound. | |||
T18534 |
PEG4-aminooxy-MMAF
|
Others | Others |
PEG4-aminooxy-MMAF is a drug-linker conjugate designed for antibody-drug conjugates (ADC) that exhibits potent antitumor activity. It incorporates MMAF, a powerful antitubulin agent, connected through a non-cleavable PEG4 linker[1]. | |||
T16122 |
MMAF sodium
Monomethylauristatin F sodium |
ABC | Membrane transporter/Ion channel |
MMAF sodium is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A. MMAF sodium is an effective tubulin polymerization inhibitor and is used as an antitumor agent. | |||
T19269 |
D8-MMAF hydrochloride
|
Others | Others |
D8-MMAF hydrochloride is a deuterated form of MMAF hydrochloride, which is a microtubule destroyer. | |||
T27975 |
MAL-PEG4-MMAF
|
||
MAL-PEG4-MMAF is a maleimido functionalized derivative of MMAF (Monomethyl auristatin F) with PEG4 linker. The maleimido functional group can be easily conjugated to protein carriers (such as antibody or enzyme). MAL-PEG4-MMAF is a useful precursor for ma | |||
T18306 |
MC-Alkyl-Hydrazine Modified MMAF
|
Others | Others |
MC-Alkyl-Hydrazine Modified MMAF is a potent antitumor drug-linker conjugate for ADC, incorporating Modified MMAF, a tubulin inhibitor, through a noncleavable MC-Alkyl-Hydrazine linkage[1]. | |||
T18326 |
MC-Val-Cit-PAB-MMAF
|
Others | Others |
MC-Val-Cit-PAB-MMAF is an antibody-drug conjugate (ADC) component that exhibits antitumor properties through the action of the tubulin inhibitor, monomethyl auristatin F (MMAF), which is connected by a cathepsin-cleavable linker, MC-Val-Cit-PAB. | |||
T18251 |
MAL-di-EG-Val-Cit-PAB-MMAF
|
Others | Others |
MAL-di-EG-Val-Cit-PAB-MMAF refers to a chemical compound that comprises the linker (MAL-di-EG-Val-Cit-PAB) and the potent blocker of tubulin polymerization (MMAF, Monomethyl auristatin F)[1]. | |||
T74177 | Modified MMAF | ||
Modified MMAF 是一种用于构建 Antibody-drug Conjugate (ADC) 的 ADC 细胞毒素,适用于癌症靶向研究。 | |||
T82382 |
Fmoc-MMAF-OMe
|
||
Fmoc-MMAF-OMe,一种具有Fmoc保护基团的抗癌剂和微管蛋白聚合抑制剂,其活性成分MMAF作为经典抗体偶联药物(ADCs)中的细胞毒性(ADC Cytotoxin)组分。 | |||
T83129 |
Amidate-VC-PAB-MMAF
|
||
Amidate-VC-PAB-MMAF 是结合了可降解的ADC linker (Amidate-VC-PAB) 与有效微管蛋白聚合抑制剂MMAF的化合物。其应用于抗体偶联活性分子(ADC)的合成,并能减少ADC的脱靶效应。 | |||
T80883 |
Val-Cit-PAB-MMAF
|
||
Val-Cit-PAB-MMAF为抗体偶联药物(ADC)活性组分,其结构由ADC linker(肽Val-Cit-PAB)与高效的微管蛋白聚合抑制剂MMAF通过偶联形成。 | |||
T81715 |
N3-PEG3-VC-PAB-MMAF
|
||
N3-PEG3-VC-PAB-MMAF(Comp T-88-5)为药物连接物偶联物,结合了ADC连接物N3-PEG3-VC-PAB与微管蛋白抑制剂MMAF,作为点击化学试剂,在具有Azide基团的特点下,能够通过铜催化叠氮-炔环加成反应(CuAAc)与含Alkyne基团的分子反应,同时也能通过菌株促进炔-叠氮环加成反应(SPAAC)与含DBCO或BCN基团的分子作用。 | |||
T77894 |
Val-Cit-PAB-MMAF sodium
|
||
Val-Cit-PAB-MMAFsodium为抗体药物偶联物(ADC)的活性组分,其结构由ADC连接子(肽类连接子Val-Cit-PAB)与高效微管蛋白聚合抑制剂MMAF通过偶联形成。 | |||
T77892 |
Mal-PEG8-Val-Cit-PAB-MMAF
|
||
Mal-PEG8-Val-Cit-PAB-MMAF 是一种用于抗体药物偶联体 (ADC) 的药物-连接物复合体 (drug-linker conjugate for ADC)。该化合物由一个可降解的 ADC linker 以及有效的微管蛋白抑制剂 MMAE 组成。 | |||
T16031 |
McMMAF
Maleimidocaproyl monomethylauristatin F |
Microtubule Associated | Cytoskeletal Signaling |
McMMAF 是一种保护基团共轭的 MMAF。它是一种具有马来酰亚胺基己酰基接头(MC 接头)的 MMAF 衍生物, MMAF 是一种有效的微管蛋白聚合抑制剂。它可与抗体或其他蛋白质或生物聚合物结合。 | |||
T74880 |
Cys-McMMAF
|
||
Cys-McMMAF 是 AlMcMMAF 释放的有效载荷,AlMcMMAF 是一种抗 5T4 的人源化 A1 抗体,通过马来酰咪唑丙基连接物偶联到微管破坏 MMAF 。Cys-McMMAF 对两种肿瘤小鼠模型(H1975 和 MDA-MB-361-DYT2 模型) 均有抑癌效果。 |